International Journal of Infectious Diseases (Jul 2018)

Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection

  • Wan Beom Park,
  • Leo L.M. Poon,
  • Su-Jin Choi,
  • Pyoeng Gyun Choe,
  • Kyoung-Ho Song,
  • Ji Hwan Bang,
  • Eu Suk Kim,
  • Hong Bin Kim,
  • Sang Won Park,
  • Nam Joong Kim,
  • Malik Peiris,
  • Myoung-don Oh

Journal volume & issue
Vol. 72
pp. 8 – 10

Abstract

Read online

Background: Information on the duration of replicative Middle East respiratory syndrome coronavirus (MERS-CoV) shedding is important for infection control. The detection of MERS-CoV sub-genomic mRNAs indicates that the virus is replicative. This study examined the duration for detecting MERS-CoV sub-genomic mRNA compared with genomic RNA in diverse respiratory specimens. Methods: Upper and lower respiratory samples were obtained from 17 MERS-CoV-infected patients. MERS-CoV sub-genomic mRNA was detected by reverse transcription PCR (RT-PCR) and MERS-CoV genomic RNA by real-time RT-PCR. Results: In sputum and transtracheal aspirate, sub-genomic mRNA was detected for up to 4 weeks after symptoms developed, which correlated with the detection of genomic RNA. In oropharyngeal and nasopharyngeal swab specimens, the detection of sub-genomic mRNA and genomic RNA did not correlate. Conclusions: These findings suggest that MERS-CoV does not replicate well in the upper respiratory tract. Keywords: Coronavirus infections, RNA, Messenger, Respiratory system